Medical Auditing and Review Solutions for Infectious Disease Practices

Medical auditing and review examines how clinical work becomes documented, coded, billed, paid, and followed through the revenue cycle. For infectious disease practices, that can include office visits, hospital consults, infusion administration, drug claims, OPAT services, authorization, denials, underpayments, and aging accounts receivable. The goal is to identify where revenue is delayed, lost, or left uncollected and connect each issue to its operational source.

Infectious disease practices often combine cognitive services with infusion, OPAT, buy-and-bill drug activity, specialty drugs, and contracted or hospital-related services. Each area can involve different documentation, coding, authorization, benefit, payment, and contract considerations. A specialty-specific review helps examine those interactions instead of treating the practice like a general medical office, making it easier to identify workflow gaps and reimbursement issues affecting the full operating model.

Yes. Payment reconciliation can compare expected reimbursement with payments for drug, administration, and E/M claims. The review can flag short-pays, incorrect fee schedule application, unit mismatches, and NDC mismatches. Contract and coverage agreement review can also examine whether payers are following applicable terms for drugs, infusion administration, consult services, hospital coverage, and stewardship agreements.

Denial analysis can address issues involving drug and administration coding, missing authorization, medical-versus-pharmacy benefit confusion, and under-documented consults. Denials are categorized by root cause and can support payer-specific appeals backed by clinical documentation. Findings can also be shared with clinical, coding, and front-office teams so the practice can address recurring causes rather than only resolving individual claims.

Claims management and overflow support can cover charge entry, coding review, claim scrubbing, submission, and rejection clearing for E/M, infusion, and drug claims. Support may be structured around the practice’s existing systems and operating needs. The purpose is to help reduce administrative burden while giving the practice clearer visibility into claims status, recurring issues, and the workflow points contributing to backlogs.

Authorization support can include eligibility and benefit verification, determining whether therapy falls under the medical or pharmacy benefit, and managing prior authorization requests for infusions, OPAT courses, and specialty drugs. Requests can be tracked through the workflow so the practice has clearer visibility into outstanding requirements, authorization status, and the financial exposure associated with therapy that may otherwise remain unreimbursed.

The resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They can support practices evaluating revenue streams, launching or reviewing infusion and OPAT operations, adding providers, examining claims and payment performance, or understanding why collections do not align with the work being performed.

GrowInfectiousDisease does not publish invented rates, drug acquisition costs, payment rates, or margin figures. Its tools allow practices to apply their own numbers rather than relying on generalized assumptions. This approach helps users evaluate their own revenue streams and operating decisions while keeping unknown or practice-specific information clearly distinguished from verified information.